Statistics
Publications
22
Citations
1.4K
H-Index
16
Active since
2008
Samar Alsafadi is an author at Inserm specializing in medicine, oncology, and molecular oncology.
Publications per year
2008–2024
22
22
Clonal heterogeneity of acute myeloid leukemia treated with the IDH2 inhibitor enasidenib
Lynn Quek, Muriel D. David, Alison Kennedy et al. · Nature Medicine · 2018 · 200 citations · Full text
Medicine, Hematology, Oncology +16
1–5 of 22